🧬 Biotech & Pharmaceutical IP Strategy

Scientific Innovation. Strategic Protection. Commercial Readiness.

At Verus IP, we specialize in helping biotechnology and pharmaceutical companies unlock the full value of their intellectual property. Led by professionals, we bring advanced legal insight, scientific literacy, and commercial strategy to every engagement — without stepping into the territory of litigation representation.

We work alongside R&D teams, and in-house/external counsel to provide business-focused IP consulting that supports patent strategy, licensing readiness, and long-term asset growth.

✅ What We Do

📈 IP Commercialization Strategy

We help you transform innovation into monetizable assets. From early-stage discovery through clinical development, we craft commercialization strategies that align IP with your therapeutic pipeline, market goals, and regulatory path.

🧠 Patent Landscape & Competitive Analysis

Our team conducts technical and commercial assessments of the patent landscape around your lead candidates and platforms. We identify white space, monitor competitor filings, and generate strategic reports that guide R&D and business development.

🤝 Licensing Readiness & Deal Structuring Support

Whether you’re licensing in, out, or co-developing IP, we help build the framework. We draft non-binding term sheets, assess royalty models, and prepare data rooms and license briefing packages—so your team is ready for pharma partnerships, VC due diligence, or tech transfer.

🧾 IP Asset Documentation & Management

From invention disclosure workflows to internal IP tracking systems, we help life sciences companies implement processes that protect proprietary methods, data, and materials—especially those not covered by formal patents. Our strategies prioritize trade secrets, SOPs, and secure technical documentation.

🧬 Regulatory-Linked IP Strategy

We support your regulatory team by aligning IP timelines with FDA submission milestones, orphan drug exclusivity, patent term extension (PTE) opportunities, and data exclusivity windows under Hatch-Waxman or the Biologics Price Competition and Innovation Act (BPCIA).

🧪 Ideal for:

  • Pre-clinical and clinical-stage biotech startups

  • Pharmaceutical companies preparing for IND/NDA filings

  • University spinouts and academic research labs

  • Venture capital firms evaluating life sciences IP portfolios

  • Licensing and tech transfer teams looking to optimize deal terms

💡 What Makes Verus IP Different?

✔ J.S.M.-Trained Professionals
We bridge the gap between law, science, and business—offering the deep analytical perspective of IP law without providing legal advice.

✔ Sector-Specific Experience
We focus on the unique needs of life sciences companies: regulatory IP strategies, high-stakes licensing, and investor-grade documentation.

✔ Non-Legal, Strategic Focus
We don’t file patents—we strengthen them. Our goal is to support your attorneys and business teams with clear, actionable guidance that moves the IP from asset to advantage.

✔ Flexible Engagement Models
Whether you need a one-time audit, project-based licensing support, or ongoing IP strategy advising, our services scale with your needs.

In biotech and pharma, IP isn't just protection—it's leverage.
Let Verus IP help you build an intellectual property strategy that supports innovation, partnership, and growth.

👉 Contact us today to discuss how we can support your IP strategy, licensing roadmap, or investor readiness in the life sciences space.